Sign Out
VaxigripTetra (split virion, inactivated) is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine for: active immunisation of adults, including pregnant women, and children from 6 months of age and older; passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see Precautions, Use in Pregnancy & Lactation and Pharmacology: Pharmacodynamics under Actions).
The use of VaxigripTetra should be based on official recommendations.
